Skip to main content
. 2024 Oct 25;7(10):e2440286. doi: 10.1001/jamanetworkopen.2024.40286

Figure 1. Flowchart Demonstrating the Selection of Study Participants for the Survival Analysis.

Figure 1.

The national cohort was derived from the European Ancestry Veterans from the Million Veteran Program (MVP), release 4. ESKD indicates end-stage kidney disease; GLP-1RA, glucagon-like peptide 1 receptor agonist; GRS, genetic risk score.